White House Directs Federal Agencies to Expand Psychedelic Drug Access

Summary: In April 2026, the White House issued an Executive Order to make psychedelic drugs, like ibogaine, easier to access for people with serious mental illness. Because suicide rates are rising—especially among veterans—and standard medicines aren't always working, the government wants to try new solutions. The order tells agencies like the FDA, DEA, and HHS to speed up research, share data, and create ways for patients to try these breakthrough therapies sooner.

Source: rssapp-clinicaladvisor-com URL: psychiatryadvisor.com/news/white-house-directs-federal-agencies-to-expand-psychedelic-drug-access/ (opens in new tab)